0001708138-20-000030.txt : 20200403 0001708138-20-000030.hdr.sgml : 20200403 20200403165023 ACCESSION NUMBER: 0001708138-20-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20774179 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-04-01 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Finance CFO Common Stock 2020-04-02 4 S 0 69 495.24 D 25092 D Common Stock 2020-04-02 4 S 0 11 496.28 D 25081 D Common Stock 2020-04-02 4 S 0 25 497.48 D 25056 D Common Stock 2020-04-03 4 S 0 121 489.5 D 24935 D Common Stock 2020-04-03 4 S 0 50 490.66 D 24885 D Common Stock 2020-04-03 4 S 0 25 492.76 D 24860 D Common Stock 2020-04-03 4 S 0 99 493.51 D 24761 D Common Stock 2020-04-03 4 S 0 172 494.42 D 24589 D Common Stock 2020-04-03 4 S 0 2 495.56 D 24587 D Common Stock 2020-04-03 4 S 0 54 496.33 D 24533 D Common Stock 2020-04-03 4 S 0 25 497.6 D 24508 D Common Stock 2020-04-03 4 S 0 62 498.8 D 24446 D Common Stock 2020-04-03 4 S 0 73 499.37 D 24373 D Common Stock 172 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 272.7 2020-04-01 4 M 0 2500 0.0 D 2023-09-09 Common Stock 2500 52000 D Non-Qualified Stock Option (right to buy) 272.7 2020-04-01 4 M 0 2000 0.0 D 2023-09-09 Common Stock 2000 50000 D Non-Qualified Stock Option (right to buy) 272.7 2020-04-01 4 M 0 1500 0.0 D 2023-09-09 Common Stock 1500 48500 D Non-Qualified Stock Option (right to buy) 272.7 2020-04-02 4 M 0 3000 0.0 D 2023-09-09 Common Stock 3000 45500 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 69 shares of Company stock on April 2, 2020 at prices ranging from $495.15 to $495.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 50 shares of Company stock on April 3, 2020 at prices ranging from $490.45 to $490.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price. Represents volume-weighted average price of sales of 99 shares of Company stock on April 3, 2020 at prices ranging from $493.02 to $493.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price. Represents volume-weighted average price of sales of 172 shares of Company stock on April 3, 2020 at prices ranging from $494.01 to $494.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price. Represents volume-weighted average price of sales of 25 shares of Company stock on April 3, 2020 at prices ranging from $497.35 to $497.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price. Represents volume-weighted average price of sales of 62 shares of Company stock on April 3, 2020 at prices ranging from $498.77 to $498.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price. Represents volume-weighted average price of sales of 73 shares of Company stock on April 3, 2020 at prices ranging from $499.09 to $499.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. Form two of two /s/**Robert E. Landry 2020-04-03